{
    "medicine_id": "4ca1aa724c4e8e96cb8e03f2c5b4a2323172a494",
    "platform_id": "DB01426",
    "metadata": {
        "name": "Humatin 250 mg 1 Capsule",
        "composition": "250 mg 1 Ajmaline",
        "clinical_particulars": {
            "therapeutic_indications": "For use as an antiarrhythmic agent",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Ajmaline is a class 1A antiarrhythmic agent By interfering with the sodium channels this drug allows for improvement in abnormal rhythms of the heart",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01118",
                        "description": "Amiodarone may increase the QTc prolonging activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Fingolimod may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Propafenone may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Glimepiride may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Metoprolol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "Lidocaine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "Mexiletine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Acetyldigitoxin may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Lercanidipine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Magnesium sulfate may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "Tocainide may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Deslanoside may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Carvedilol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Practolol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00521",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Carteolol"
                    },
                    {
                        "drugbank-id": "DB01214",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Metipranolol"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Aprindine"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nimesulide"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Clevidipine"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Seletracetam"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Sparteine"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tranilast"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Fasudil"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Agmatine"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Darodipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Niludipine"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Spiradoline"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Cymarin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13635",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tiracizine"
                    },
                    {
                        "drugbank-id": "DB13645",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Ethacizine"
                    },
                    {
                        "drugbank-id": "DB13718",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Hydroquinine"
                    },
                    {
                        "drugbank-id": "DB13746",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Bioallethrin"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tertatolol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Caroverine"
                    },
                    {
                        "drugbank-id": "DB13863",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Fosfructose"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "Ajmaline may increase the arrhythmogenic activities of WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Fish oil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB15300",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Hydroquinidine"
                    },
                    {
                        "drugbank-id": "DB15366",
                        "description": "Ajmaline may increase the arrhythmogenic activities of SOR C13"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Adenosine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Loperamide"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Flecainide"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Azimilide"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Eperisone"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Benidipine"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Simendan"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Sotalol"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Procainamide"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Terodiline"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Pregabalin may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "Trimethadione may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Amlodipine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Hyoscyamine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "Ethosuximide may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Nicardipine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Verapamil may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Losartan may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "Levomenthol may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Felodipine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Nitrendipine may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "Perhexiline may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Bretylium may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "Encainide may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Digitoxin may increase the arrhythmogenic activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Methsuximide"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Cariporide"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "Ajmaline may increase the arrhythmogenic activities of Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Ajmaline may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pheniramine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Farnesyl thiopyrophosphate"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Ajmaline can be increased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Ajmaline may increase the QTc prolonging activities of Pitolisant"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Ajmaline"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Ajmaline may increase the QTc prolonging activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Ajmaline"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}